As of 2025-06-26, the Relative Valuation of Moderna Inc (MRNA) is (96.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.86 USD, the upside of Moderna Inc based on Relative Valuation is -458.8%.
The range of the Relative Valuation is (94.64) - (99.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 11.4x | 10.7x |
| Forward P/E multiples | 10.9x - 12.1x | 11.5x |
| Fair Price | (94.64) - (99.16) | (96.38) |
| Upside | -452.4% - -469.2% | -458.8% |
| Date | P/E |
| 2025-06-24 | -3.09 |
| 2025-06-23 | -2.96 |
| 2025-06-20 | -2.98 |
| 2025-06-18 | -2.93 |
| 2025-06-17 | -2.94 |
| 2025-06-16 | -2.99 |
| 2025-06-13 | -3.07 |
| 2025-06-12 | -3.15 |
| 2025-06-11 | -3.20 |
| 2025-06-10 | -3.19 |
| 2025-06-09 | -3.24 |
| 2025-06-06 | -3.16 |
| 2025-06-05 | -3.01 |
| 2025-06-04 | -3.14 |
| 2025-06-03 | -3.20 |
| 2025-06-02 | -3.12 |
| 2025-05-30 | -3.06 |
| 2025-05-29 | -3.10 |
| 2025-05-28 | -3.00 |
| 2025-05-27 | -3.08 |
| 2025-05-23 | -3.02 |
| 2025-05-22 | -3.08 |
| 2025-05-21 | -2.97 |
| 2025-05-20 | -3.22 |
| 2025-05-19 | -3.04 |
| 2025-05-16 | -2.86 |
| 2025-05-15 | -2.72 |
| 2025-05-14 | -2.77 |
| 2025-05-13 | -2.94 |
| 2025-05-12 | -2.96 |
| 2025-05-09 | -2.79 |
| 2025-05-08 | -2.81 |
| 2025-05-07 | -2.77 |
| 2025-05-06 | -2.81 |
| 2025-05-05 | -3.21 |
| 2025-05-02 | -3.18 |
| 2025-05-01 | -3.11 |
| 2025-04-30 | -3.29 |
| 2025-04-29 | -3.20 |
| 2025-04-28 | -3.16 |
| 2025-04-25 | -3.13 |
| 2025-04-24 | -3.15 |
| 2025-04-23 | -3.06 |
| 2025-04-22 | -2.96 |
| 2025-04-21 | -2.89 |
| 2025-04-17 | -2.85 |
| 2025-04-16 | -2.90 |
| 2025-04-15 | -3.02 |
| 2025-04-14 | -3.09 |
| 2025-04-11 | -3.02 |